Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its 2020 financial results and provide a business update at 8:30 a.m. ET on Thursday, March 18, 2021.
Ocugen will issue a pre-market earnings announcement the same day. Investors are invited to participate on the call using the following details:
| Dial-In Number: | (844) 873-7330 (U.S.) or (602) 563-8473 (international) |
| Conference ID: | ID 2375087 |
| Webcast: | Available in the “Investors” section of the Ocugen website by clicking here and archived for approximately 45 days following the call https://finance.yahoo.com/news/ocugen-host-conference-call-thursday-224500156.html |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.